Point72 Asset Management
INSY

Point72 Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Point72 Asset Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-435,000
Closed -$4.57M – 1125
2017
Q1 		$4.57M Buy
435,000
+86,373
+25% +$920K 0.03% 545
2016
Q4 		$3.21M Sell
348,627
-18,516
-5% -$209K 0.03% 506
2016
Q3 		$4.33M Buy
+367,143
New +$5.58M 0.03% 444
2015
Q2 		– Sell
-65,200
Closed -$1.9M – 938
2015
Q1 		$1.9M Sell
65,200
-1,142,300
-95% -$30.2M 0.02% 561
2014
Q4 		$25.5M Sell
1,207,500
-144,030
-11% -$2.85M 0.19% 179
2014
Q3 		$26.2M Buy
1,351,530
+1,014,130
+301% +$15.9M 0.22% 143
2014
Q2 		$5.27M Buy
+337,400
New +$5.45M 0.04% 446

Other funds holding INSY

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return